// company-profile

Attovia Therapeutics, Inc. Insider Trading

ATTO

Every SEC Form 4 insider trading filing for Attovia Therapeutics, Inc. (ATTO) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.

SectorBiological Products, (No Diagnostic Substances)Inc.DEFilings8Insiders9
// api This Attovia Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
curl "https://api.form4api.com/v1/transactions?ticker=ATTO" -H "X-Api-Key: YOUR_API_KEY"

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 8 insiders purchased shares (net $10.0M). Buying was led by Frazier Life Sciences XI, L.P..

// 90-day insight

Over the last 90 days, Attovia Therapeutics, Inc. insiders bought $10.0M across 8 transactions with no open-market sales.

  • Most active insider: Frazier Life Sciences XI, L.P. with 9 transactions totaling $10.0M.
  • Largest single purchase: $10.0M by Frazier Life Sciences XI, L.P. on Aug 6, 2026.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 6, 2026Frazier Life Sciences XI, L.P.ATTO
C
8,930,685$0.00$0K
Aug 6, 2026Frazier Life Sciences XI, L.P.ATTO
C
1,590,175
Aug 6, 2026Frazier Life Sciences XI, L.P.ATTO
C
1,189,940
Aug 6, 2026Frazier Life Sciences XI, L.P.ATTO
C
961,322
Aug 6, 2026Frazier Life Sciences XI, L.P.ATTO
Purchase
588,235$17.00$10.00M

11 more transactions hidden

Free account · No credit card required

Building something? Get API access →